Sonoma pharmaceuticals to exhibit at upcoming cphi conference in frankfurt, germany

Boulder, co / accesswire / october 6, 2022 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye, oral and nasal care, and dermatological conditions, announced that it will be exhibiting at the cphi conference in frankfurt, germany on november 1-3, 2022. sonoma pharmaceuticals is seeking to expand its presence in the european union by adding new partners and distributors for its dermatology products, including treatments for scar management, atopic dermatitis and acne.
SNOA Ratings Summary
SNOA Quant Ranking